Business · 29/11/2017

FDA Announces Draft Guidance for Dual 510(k) and CLIA Waiver by Application Studies

The FDA is releasing a draft guidance that outlines study designs for obtaining both 510(k) clearance and CLIA waived categorization for new In Vitro Diagnostic devices, aiming to streamline the process and bring more accurate devices to patients and providers.